149 related articles for article (PubMed ID: 37390274)
1. Effect of Chinese Medicines combined with transarterial chemoembolization on primary hepatic carcinoma: A systematic review and meta-analysis.
Xu J; Shan Y; Zhang C; Hong Z; Qiu Y
Medicine (Baltimore); 2023 Jun; 102(26):e34165. PubMed ID: 37390274
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
[TBL] [Abstract][Full Text] [Related]
3. Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population.
Jia S; Fu Y; Tao H
Pharm Biol; 2020 Dec; 58(1):771-784. PubMed ID: 32767901
[TBL] [Abstract][Full Text] [Related]
4. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Liu L; Wang D; Li H; Su C; Guo X
Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.
Liu HF; Zou LQ; Lu XR; Sheng Y; Wang Q; Ding JL; Shi L; Liu SQ; Xing W
J Magn Reson Imaging; 2020 Oct; 52(4):1019-1028. PubMed ID: 31675170
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis.
Zhang L; Hu P; Chen X; Bie P
PLoS One; 2014; 9(6):e100305. PubMed ID: 24945380
[TBL] [Abstract][Full Text] [Related]
10. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Wang L; Ke Q; Lin N; Huang Q; Zeng Y; Liu J
Int J Hyperthermia; 2019; 36(1):1288-1296. PubMed ID: 31852267
[No Abstract] [Full Text] [Related]
12. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the efficacy and safety of iodine [
Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Huo YR; Eslick GD
JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis.
Wang DY; Liu L; Qi XS; Su CP; Chen X; Liu X; Chen J; Li HY; Guo XZ
Asian Pac J Cancer Prev; 2015; 16(13):5573-8. PubMed ID: 26225712
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang X; Wang K; Wang M; Yang G; Ye X; Wu M; Cheng S
Oncotarget; 2017 Apr; 8(17):29416-29427. PubMed ID: 28177886
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter Arterial Chemoembolization Plus
Zhu ZX; Liao MH; Wang XX; Huang JW
Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
Wang L; Ke Q; Lin N; Zeng Y; Liu J
Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
